Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. scores highest on Nitro (67) and lowest on Price (30). Its PosiPenta is 48.88 out of 100, around the middle of similar companies.
On the Penta Grid this week, Agios Pharmaceuticals, Inc. is Grid #302 of 837 in the Healthcare sector in United States, and Grid #2,007 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | 48.88 | 30 | 32 | 67 | 61 | 54 |
| Biohaven Ltd. | 29.24 | 0 | 38 | 58 | 2 | 47 |
| Progyny, Inc. | 65.30 | 36 | 85 | 81 | 72 | 52 |
| Vericel Corporation | 56.25 | 18 | 75 | 78 | 60 | 49 |
| Fortrea Holdings Inc. | 52.56 | 16 | 72 | 96 | 39 | 40 |
| Celldex Therapeutics, Inc. | 42.26 | 21 | 20 | 57 | 65 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.47 |
| P/B ratio | 1.82 |
EEarnings
| Trailing EPS | ₹-663.95 |
| Forward EPS | ₹-380.89 |
NNitro
| Price | 2966.47 |
| 52-week high | 4356.89 |
| 52-week low | 2106.46 |
| Fall from 52-week high | 31.9% |
TTorque
| Return on equity (ROE) | -34.34% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | 0.63 |
| Market cap | ₹17,710 Cr |
| Insider holding | 1.07% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Agios Pharmaceuticals, Inc.'s PosiPenta score?
Agios Pharmaceuticals, Inc.'s PosiPenta is 48.88 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Agios Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Agios Pharmaceuticals, Inc. is Grid #302 of 837 in the Healthcare sector in United States, and Grid #2,007 of 4,000 in United States.
Which PosiPenta pillar is strongest for Agios Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 67 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Agios Pharmaceuticals, Inc.?
Price (valuation), with a score of 30 out of 100: weaker than most similar companies.
Has Agios Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.58 points, from 46.30 to 48.88.
PositoAI is for research and education only and is not investment advice.